Positioning injection device for tumor bearing of mouse with in-situ lung cancer
By designing an injection device with a fixed angle puncture drive mechanism and limiting parts, the problem of difficulty and high mortality in tumor-bearing injection in mice with orthotopic lung cancer is solved, and the syringe is punctured at a fixed angle and deep, improving the success of tumor-bearing Rate.
Patent Information
- Application Number
- CN202411048063.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-15
AI Technical Summary
The injection operation of tumor-bearing mice with orthotopic lung cancer is very difficult, resulting in low mortality and tumor-bearing success in mice. In particular, the lung injection technology requires complexity and the puncture depth and angle are difficult to accurately grasp, which can easily damage the heart.
An injection device including an angled puncture drive mechanism and a limiting member is designed to fix the syringe through a magnetic base, a guide groove body, a screw and a handle to ensure that the syringe advances at a fixed angle, and to define the puncture depth through the limiting member to ensure that the Puncture accuracy.
It reduces the difficulty of injection operation, avoids heart damage, and significantly improves the success rate of tumor bearing in orthotopic lung cancer in mice.
Smart Images

Figure CN118948484A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical instruments, and in particular to an in situ tumor-bearing injection device. Background Art
[0002] Lung cancer is the malignant tumor with the highest morbidity and mortality among all tumors, which seriously threatens human life and health. In order to conquer lung cancer as soon as possible, the mouse lung cancer model has become an indispensable tool for the development of lung cancer treatment methods. The mouse models of lung cancer mainly include gene-edited mice, orthotopic tumor-bearing mice and subcutaneous tumor-bearing mice. Gene-edited mice are expensive and have a single gene locus, so they cannot be used by researchers on a large scale; subcutaneous tumor-bearing mice are tumor cells injected into the subcutaneous part of mice to form tumors, which cannot truly simulate the tumor microenvironment of lung cancer, resulting in subsequent studies that cannot truly reveal the pathogenesis of lung cancer; orthotopic tumor-bearing mice are tumor cells injected into the lungs to form tumors in the lungs, which can truly reflect the tumor microenvironment of lung cancer and provide strong support for subsequent researchers to reveal the pathogenesis of lung cancer. At present, orthotopic lung cancer mice are mainly injected through tracheal injection and lung injection. Tracheal injection is to inject tumor cells into the lungs through intubation technology, which has high technical requirements and requires customized catheters, which are easily inserted into the esophagus by mistake. Lung injection is the most direct and simple, but the injection operation is extremely difficult. It is difficult for researchers to accurately control the puncture depth and angle. Deviations in the puncture depth and angle can easily damage the heart adjacent to the lungs and cause the death of mice.
[0003] Invention patent content
[0004] In view of this, the purpose of the present invention is to provide a positioning injection device for in situ lung cancer mouse tumor-bearing, so as to solve the technical problems of reducing the difficulty of injection operation of in situ lung cancer mouse tumor-bearing, reducing mouse mortality and tumor-bearing success rate.
[0005] The patent of the present invention is a positioning injection device for in situ lung cancer mouse tumor-bearing, comprising a syringe and an injection needle connected to the syringe, as well as a fixed-angle puncture drive mechanism for driving the syringe to move forward at a fixed tilt angle and a limiter arranged on the injection needle to limit the puncture depth.
[0006] Furthermore, the fixed-angle puncture drive mechanism includes a magnetic base, a guide groove body obliquely arranged on the magnetic base, a syringe fixing block slidingly matched with the inclined guide groove on the guide groove body, a screw rotatingly matched with the rear end of the guide groove body and threadedly matched with the syringe fixing block, and a handle arranged at the rear end of the screw, and the length direction of the inclined guide groove is parallel to the length direction of the screw.
[0007] Furthermore, the syringe fixing block is provided with a round hole for installing the syringe and a screw for locking the syringe.
[0008] Furthermore, the limiting member is a circular member composed of a conical segment and a cylindrical segment.
[0009] Furthermore, the angle between the generatrix of the cone segment and the axis of the cone segment is less than or equal to the angle between the length direction of the inclined guide groove and the horizontal plane.
[0010] Furthermore, the angle between the length direction of the inclined guide groove and the screw and the horizontal plane is 45°.
[0011] Beneficial effects of the invention patent:
[0012] The positioning injection device for in situ lung cancer tumor-bearing mice of the present invention can control the injector to perform puncture at a fixed angle, and the puncture depth is limited by a limiter provided on the injection needle, so that the front end of the puncture needle can be ensured to accurately reach a predetermined position, thereby reducing the difficulty of injection puncture operation, effectively avoiding the problem of mouse death caused by puncturing the heart, and significantly improving the success rate of in situ lung cancer tumor-bearing mice. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] Figure 1 Schematic diagram of the structure of the localized injection device used for orthotopic lung cancer tumor-bearing mice. DETAILED DESCRIPTION
[0014] The present invention will be further described below in conjunction with the accompanying drawings and embodiments.
[0015] As shown in the figure, the positioning injection device for in situ lung cancer tumor-bearing mice in this embodiment includes a syringe 1 and an injection needle 2 connected to the syringe, and also includes a fixed-angle puncture drive mechanism that drives the syringe to move forward at a fixed tilt angle and a limiter 3 arranged on the injection needle to limit the puncture depth.
[0016] In this embodiment, the fixed-angle puncture drive mechanism includes a magnetic base 4, a guide slot body 5 obliquely arranged on the magnetic base, a syringe fixing block 6 slidingly matched with the oblique guide slot on the guide slot body, a screw 7 rotatingly matched with the rear end of the guide slot body and threadedly matched with the syringe fixing block, and a handle 8 arranged at the rear end of the screw, and the length direction of the oblique guide slot is parallel to the length direction of the screw. In a specific implementation, a rolling bearing can be used to connect the rear end of the guide slot body 5 and the screw 7 to ensure that the screw 7 can rotate flexibly and at the same time ensure that the screw cannot move axially.
[0017] In this embodiment, the syringe fixing block is provided with a round hole for installing the syringe and a screw 9 for locking the syringe; after the syringe is inserted into the round hole on the syringe fixing block, the syringe can be fixed by tightening the screw 9, and the syringe can be removed by loosening the screw, which is simple and convenient to operate.
[0018] In this embodiment, the stopper 3 is a circular member composed of a conical section 31 and a cylindrical section 32. In a specific implementation, the stopper 3 can be made of a rubber member, so that the stopper 3 can be conveniently put on the injection needle 2, and the elastic force of the rubber can be used to stably fix the stopper 3 on the injection needle, and it is also convenient to adjust the fixed position of the stopper on the injection needle.
[0019] In this embodiment, the angle between the generatrix of the cone segment and the axis of the cone segment is less than or equal to the angle between the length direction of the inclined guide groove and the horizontal plane. This can better ensure that the front end of the cone segment is in contact with the mouse skin during the puncture process, which is conducive to improving the positioning accuracy of the puncture depth.
[0020] In this embodiment, the angle between the inclined guide groove and the length direction of the screw and the horizontal plane is 45°, which is convenient for puncture and has good operation convenience.
[0021] When carrying out in situ lung cancer tumor, the mouse is fixed on the anesthesia platform, and the positioning injection device for in situ lung cancer mouse tumor in this embodiment is fixed on the anesthesia table through the magnetic base 4. The magnetic base 4 facilitates the installation of the positioning injection device on the anesthesia table and the adjustment of the installation position. During puncture, the screw 7 is rotated by the handle 8 to control the injection to move forward. When the front end of the conical section 31 of the limiter 3 contacts the mouse skin, the puncture is stopped, and the operation is simple; after the puncture is in place, the syringe piston is pushed forward to inject the tumor cells in the syringe into the mouse lungs. The positioning injection device for in situ lung cancer mouse tumor in this embodiment can control the syringe to puncture at a fixed angle, and the depth of the puncture is limited by the limiter set on the injection needle, so that the front end of the puncture needle can be ensured to reach the predetermined position accurately, thereby reducing the difficulty of injection puncture, avoiding the problem of mouse death caused by wrong puncture of the heart, and significantly improving the success rate of in situ lung cancer tumor in mice.
[0022] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the purpose and scope of the technical solution of the present invention, which should be included in the scope of the claims of the present invention.
Claims
1. A localized injection device for orthotopic lung cancer-bearing mice, comprising a syringe and an injection needle connected to the syringe, characterized in that: It also includes a fixed-angle puncture drive mechanism for driving the syringe to advance at a fixed tilt angle and a limiter provided on the injection needle to limit the puncture depth.
2. The localized injection device for orthotopic lung cancer-bearing mice according to claim 1, characterized in that: The fixed-angle puncture drive mechanism includes a magnetic base, a guide groove body obliquely arranged on the magnetic base, a syringe fixing block slidingly engaged with the inclined guide groove on the guide groove body, a screw rotatingly engaged with the rear end of the guide groove body and threadedly engaged with the syringe fixing block, and a handle arranged at the rear end of the screw, and the length direction of the inclined guide groove is parallel to the length direction of the screw.
3. The localized injection device for in situ lung cancer-bearing mice according to claim 2, characterized in that: The syringe fixing block is provided with a circular hole for installing the syringe and a screw for locking the syringe.
4. The localized injection device for orthotopic lung cancer-bearing mice according to claim 1, characterized in that: The limiting member is a circular member consisting of a conical section and a cylindrical section.
5. The localized injection device for orthotopic lung cancer-bearing mice according to claim 4, characterized in that: The angle between the generatrix of the cone segment and the axis of the cone segment is less than or equal to the angle between the length direction of the inclined guide groove and the horizontal plane.
6. The localized injection device for orthotopic lung cancer-bearing mice according to claim 5, characterized in that: The angle between the length direction of the inclined guide groove and the screw and the horizontal plane is 45°.
Citation Information
Cited By
Cerebral cortex precise liquid injection system
CN119746210A
